CD36 as a double-edged sword in cancer

Muwei Jiang, Renske Karsenberg, Frans Bianchi, Geert van den Bogaart*

*Corresponding author voor dit werk

Onderzoeksoutputpeer review

5 Citaten (Scopus)
26 Downloads (Pure)


The membrane protein CD36 is a lipid transporter, scavenger receptor, and receptor for the antiangiogenic protein thrombospondin 1 (TSP1). CD36 is expressed by cancer cells and by many associated cells including various cancer-infiltrating immune cell types. Thereby, CD36 plays critical roles in cancer, and it has been reported to affect cancer growth, metastasis, angiogenesis, and drug resistance. However, these roles are partly contradictory, as CD36 has been both reported to promote and inhibit cancer progression. Moreover, the mechanisms are also partly contradictory, because CD36 has been shown to exert opposite cellular effects such as cell division, senescence and cell death. This review provides an overview of the diverse effects of CD36 on tumor progression, aiming to shed light on its diverse pro- and anti-cancer roles, and the implications for therapeutic targeting.

Originele taal-2English
Pagina's (van-tot)7-15
Aantal pagina's9
TijdschriftImmunology Letters
Vroegere onlinedatum19-dec.-2023
StatusPublished - feb.-2024


Duik in de onderzoeksthema's van 'CD36 as a double-edged sword in cancer'. Samen vormen ze een unieke vingerafdruk.

Citeer dit